SRC and breast carcinoma: Recent studies highlight Src as a potent target for therapeutic intervention; especially as the targeting can overcome multiple mechanisms of trastuzumab resistance in breast cancer therapeutics, because hyperactivation of Src is universally detected in the resistant cells [31, 33].